Emmanuel Amuchechukwu Kevin

Mr. Emmanuel Amuchechukwu Kevin

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2024 in Proceedings
Verified
Conference Paper
Open access
PDF file
ODOBINNA KENNETH DIDIGWU
OBINNA KENNETH DIDIGWU
EKEmmanuel Amuchechukwu Kevin
Emmanuel Amuchechukwu Kevin
MEMichael Osita Edeh
Michael Osita Edeh
SOSunday Okafor
Sunday Okafor
Pyrrolizidine alkaloids (PAs) are heterocyclic organic compounds of natural origin synthesized by either plants or microorganisms

1 January 2025 in Journal of Research in Complementary Medicine
Verified
Journal Article
Closed access
MYMubaraq Yussuf
Mubaraq Yussuf
AKAnthony Kokelu
Anthony Kokelu
EKEmmanuel Amuchechukwu Kevin
Emmanuel Amuchechukwu Kevin
MGMuftanatu Gomina
Muftanatu Gomina
SUSa Usman
Sa Usman
ABAdeola Bello
Adeola Bello
Nigeria’s rich biodiversity hosts various psychoactive plants that have been pivotal in traditional medicine and cultural practices. This review examines the medicinal uses, prevalence, and mechanisms of action of prominent Nigerian psychoactive plants, including Datura stramonium and Carica papaya. These plants, utilized for centuries, exhibit pharmacological activities such as anti-inflammatory, analgesic, and neuroactive effects, driven by their bioactive compounds like alkaloids and flavonoids. Traditional applications range from treating ailments like asthma, depression, and infections to roles in spiritual rituals. However, the recreational use and neurotoxic potential of these plants have raised public health concerns, particularly regarding substance abuse. This review highlights the need for a deeper understanding of their therapeutic benefits and risks, emphasizing the importance of culturally sensitive and evidence-based research. Insights from this study aim to inform clinical practice and shape policies to promote the safe and effective use of these plants in modern medicine.

1 January 2025 in European Journal of Scientific Research and Reviews
Verified
Journal Article
Closed access
MYMubaraq Yussuf
Mubaraq Yussuf
AKAnthony Kokelu
Anthony Kokelu
AAAyode Akinrodoye
Ayode Akinrodoye
AUAkon Usoh
Akon Usoh
EKEmmanuel Amuchechukwu Kevin
Emmanuel Amuchechukwu Kevin
MAMmaduabuchi Adimorah
Mmaduabuchi Adimorah
Diabetes mellitus is a chronic metabolic disorder with significant global health consequences due to its rising prevalence and associated complications. Current management strategies, such as blood glucose monitoring and insulin administration, often fall short in maintaining optimal glycaemic control and require high patient compliance. Nanotechnology has emerged as a breakthrough approach in diabetes management, offering innovative solutions for continuous glucose monitoring, targeted drug delivery, β-cell visualization, and the treatment of diabetes-related complications such as diabetic cardiomyopathy, macroangiopathy, and foot ulcers. This research explores the role of nanosensors in non-invasive, real-time glucose monitoring and the potential of nanocarriers to enhance the efficacy of antidiabetic drugs. Additionally, nanotechnology enables the development of closed-loop insulin delivery systems, improving treatment outcomes. Beyond glycaemic control, nanomedicine holds promise for mitigating systemic diabetic complications through organ-specific therapies, including cardiac protection and bone regeneration. However, challenges such as high production costs, scalability issues, regulatory barriers, and long-term safety concerns must be addressed for widespread clinical application. By highlighting advancements in nanotechnology-driven diabetes management and complication prevention, this work underscores the need for interdisciplinary research and collaboration to optimize these emerging technologies for better therapeutic outcomes.